|
1
|
Downs-Holmes C and Silverman P: Breast
cancer: Overview & updates. Nurse Pract. 36:20–26. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Naume B, Synnestvedt M, Falk RS, Wiedswang
G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH,
et al: Clinical outcome with correlation to disseminated tumor cell
(DTC) status after DTC-guided secondary adjuvant treatment with
docetaxel in early breast cancer. J Clin Oncol. 32:3848–3857. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG): Aromatase inhibitors versus tamoxifen
in early breast cancer: Patient-level meta-analysis of the
randomised trials. Lancet. 386:1341–1352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin H, Jie L and Ying Z: Developments in
cancer prevention and treatment using traditional Chinese medicine.
Front Med. 5:127–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi
J, Zhang W, Wei H, Sung M, Wang W and Li X: Inhibition of cancer
cell proliferation and prostaglandin E2 synthesis by Scutellaria
baicalensis. Cancer Res. 63:4037–4043. 2003.PubMed/NCBI
|
|
8
|
Chen Z and Li Y and Li Y: Review of study
on mechanism of traditional Chinese medicine in treating
autoimmunity disease. Zhong Yao Cai. 26:218–221. 2003.PubMed/NCBI
|
|
9
|
Wen MC, Wei CH, Hu ZQ, Srivastava K, Ko J,
Xi ST, Mu DZ, Du JB, Li GH, Wallenstein S, et al: Efficacy and
tolerability of anti-asthma herbal medicine intervention in adult
patients with moderate-severe allergic asthma. J Allergy Clin
Immunol. 116:517–524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ernst E: Complementary AIDS therapies: The
good, the bad and the ugly. Int J STD AIDS. 8:281–285. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chan WY, Ng TB and Yeung HW: Examination
for toxicity of a Chinese drug, the toad glandular secretory
product chan su, in pregnant mice and embryos. Biol Neonate.
67:376–380. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu SC, Fu BD, Shen HQ, Yi PF, Zhang LY, Lv
S, Guo X, Xia F, Wu YL and Wei XB: Telocinobufagin enhances the Th1
immune response and protects against Salmonella typhimurium
infection. Int Immunopharmacol. 25:353–362. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Y, Song Y, An N, Zeng S, Wang D, Yu L,
Zhu T, Zhang T, Cui J, Zhou C and Deng X: The effects of
telocinobufagin isolated from Chan Su on the activation and
cytokine secretion of immunocytes in vitro. Fundam Clin Pharmacol.
23:457–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qi F, Li A, Inagaki Y, Kokudo N, Tamura S,
Nakata M and Tang W: Antitumor activity of extracts and compounds
from the skin of the toad Bufo bufo gargarizans cantor. Int
Immunopharmacol. 11:342–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou LX and Guo JM: Research progress in
targeted therapy for hepatocellular carcinoma. J Oncol. 15:156–161.
2009.(In Chinese).
|
|
16
|
Baum B, Settleman J and Quinlan MP:
Transitions between epithelial and mesenchymal states in
development and disease. Semin Cell Dev Biol. 19:294–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomaskovic-Crook E, Thompson EW and Thiery
JP: Epithelial to mesenchymal transition and breast cancer. Breast
Cancer Res. 11:2132009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mezencev R, Matyunina LV, Jabbari N and
McDonald JF: Snail-induced epithelial-to-mesenchymal transition of
MCF-7 breast cancer cells: Systems analysis of molecular changes
and their effect on radiation and drug sensitivity. BMC Cancer.
16:2362016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang YQ, Wei XL, Liang YK, Chen WL, Zhang
F, Bai JW, Qiu SQ, Du CW, Huang WH and Zhang GJ: Over-expressed
twist associates with markers of epithelial mesenchymal transition
and predicts poor prognosis in breast cancers via ERK and Akt
activation. PLoS One. 10:e01358512015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Teschendorff AE, Journee M, Absil PA,
Sepulchre R and Caldas C: Elucidating the altered transcriptional
programs in breast cancer using independent component analysis.
PLoS Comput Biol. 3:e1612007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mironchik Y, Winnard PT Jr, Vesuna F, Kato
Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van
Diest P, et al: Twist overexpression induces in vivo angiogenesis
and correlates with chromosomal instability in breast cancer.
Cancer Res. 65:10801–10809. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fedele M, Cerchia L and Chiappetta G: The
epithelial-to-mesenchymal transition in breast cancer: Focus on
basal-like carcinomas. Cancers (Basel). 9:pii: E134. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu S, Niu N, Guo H, Tang J, Guo W, Liu Z,
Shi L, Sun T, Zhou F, Li H, et al: ARK5 promotes glioma cell
invasion, and its elevated expression is correlated with poor
clinical outcome. Eur J Cancer. 49:752–763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pardo R, Andreolotti AG, Ramos B,
Picatoste F and Claro E: Opposed effects of lithium on the MEK-ERK
pathway in neural cells: Inhibition in astrocytes and stimulation
in neurons by GSK3 independent mechanisms. J Neurochem. 87:417–426.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Noritake J, Watanabe T, Sato K, Wang S and
Kaibuchi K: IQGAP1: A key regulator of adhesion and migration. J
Cell Sci. 118:2085–2092. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang Y, Leung AW, Wang X, Zhang H and Xu
C: Effect of photodynamic therapy with hypocrellin B on apoptosis,
adhesion, and migration of cancer cells. Int J Radiat Biol.
90:575–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu Y and Zhou BP: Epithelial-mesenchymal
transition in development and diseases. Springer; New York: pp.
187–211. 2010
|
|
32
|
de Herreros AG, Peiró S, Nassour M and
Savagner P: Snail family regulation and epithelial mesenchymal
transitions in breast cancer progression. J Mammary Gland Biol
Neoplasia. 15:135–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xue G and Hemmings BA: PKB/Akt-dependent
regulation of cell motility. J Natl Cancer Inst. 105:393–404. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krepischi AC, Maschietto M, Ferreira EN,
Silva AG, Costa SS, da Cunha IW, Barros BDF, Grundy PE, Rosenberg C
and Carraro DM: Genomic imbalances pinpoint potential oncogenes and
tumor suppressors in Wilms tumors. Mol Cytogenet. 9:202016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou Q, Chen J, Feng J, Xu Y, Zheng W and
Wang J: SOSTDC1 inhibits follicular thyroid cancer cell
proliferation, migration, and EMT via suppressing PI3K/Akt and
MAPK/Erk signaling pathways. Mol Cell Biochem. 435:87–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi L, Sun X, Zhang J, Zhao C, Li H, Liu
Z, Fang C, Wang X, Zhao C, Zhang X, et al: Gab2 expression in
glioma and its implications for tumor invasion. Acta Oncol.
52:1739–1750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and De Herreros García A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
